CV Medicine Fellowship Programs

Cardiovascular Medicine 

    Curriculum - Curriculum.pdf

    Manual handbook - Handbook.pdf

    Program director -  Francisco Fuentes, M.D.

    Inquiries - cardiologyfellowships@uth.tm.edu

 

Applications

As a three-year fellowship, the Cardiovascular Disease fellowship program accepts applications of residents who anticipate completion of an ACGME accredited Internal Medicine residency program. Applications are processed through the Electronic Residency Application Service (ERAS); no other applications are accepted. All applicants are expected to participate in the National Resident Matching Program (NRMP) . The Division of Cardiology conducts three formal interview sessions each year, and seven positions at the PGY-4 level are filled from a pool of approximately 550 applicants. A minimum of three letters of recommendation from faculty members, a personal statement, Dean's letter and transcript, USMLE board scores and a completed application with a recent passport size photograph are required.

Please refer to the American Association of Medical Colleges  for more information on the ERAS program and the documentation required for application.

International graduates must meet the requirements of the Graduate Medical Education Office at The University of Texas Medical School at Houston, established by the Texas State Board of Medical Examiners and the Immigration Services Office.  The University of Texas Medical School at Houston requires international graduates to meet the terms for a Physician-in-training, as outlined by the Texas State Board of Medical Examiners, and sponsors only J-1 visas.

To allow adequate time for review and selection, applications and all supporting materials must be received through ERAS on or before December 31, 2009. The Cardiology Education Committee reviews complete fellowship applications in January. Interviews will be held on February 18, 19 and 27, 2010.  Only the leading 60-70 applicants who are among the top in academic excellence, USMLE scores, and research interests are invited for a personal interview. The interview process is an important factor in the final selection, and also gives candidates the opportunity to visit The University of Texas Medical School at Houston and meet with the faculty and fellows.

Questions regarding the Cardiovascular Disease Fellowship Program should be directed to the Cardiology Education Office at (713) 500-6577 or by E-mail to cardiologyfellowships@uth.tmc.edu.

Thank you for your interest in the Cardiovascular Disease Fellowship Program.

 

Electrophysiology

    Curriculum - EP Curriculum.pdf

    Manual handbook - EP Handbook.doc

    Program director -  Bharat,Kantharia M.D.

    Inquiries -cardiologyfellowships@uth.tmc.edu

 

Heart Failure and Transplant

    Program director - Deborah E. Meyers, MD .

    Inquiries - cardiologyfellowships@uth.tmc.edu


Interventional Cardiolology

    Curriculum - Interventional Curriculum.pdf

    Manual handbook

    Program director - Richard Smalling, M.D., Ph.D.

    Inquiries - cardiologyfellowships@uth.tmc.edu

Fellowship News

    Graduation Banquet 2010 - June 18, 2010    

    2007-2010 incoming fellows -

    Chief fellows announcement - Cardiology Chief Fellows 2008 2009.ppt

Fellowship Links

     The University of Texas System Medical Foundation - link

    Residents Handbook - pdf

    GMEIS - link

    Healthcare Risk Management & Professional Liability Insurance -link

    ACLS Recertification - link

    request for leave form.doc

    Mary Ann Lunsford Summer Externship.doc

    summer externship 2008.ppt

Sub Specialty Fellowship Applications

Thank you for your interest in our Fellowship Programs. Below you will find an application form as you requested as well as additional information you may find helpful in your decision to apply.

It is important that you complete all requested information on your application form. Please do not answer questions with ‘see CV’. We need your FLEX grades or USMLE scores on the application. If you have a license to practice medicine in Texas, please include this on your application and attach a copy. If applicable, please enclose a copy of your permanent resident card or J1 Visa (front and back), notarized ECFMG certificate, notarized medical school diploma and notarized translation. Please include a photograph of yourself with your application.

Eligible candidates for the Interventional Cardiology and Clinical Cardiac Electrophysiology Fellowship Programs must complete three years of Internal Medicine Residency and three years of Fellowship in Cardiovascular Disease in ACGME accredited programs.  Applicants must be board eligible in cardiology by the first day of training and be United States citizens, permanent residents or hold a J-1 Visa. 

Eligible candidates for our Heart Failure and Transplant Fellowship must complete three years of Internal Medicine Residency in an ACGME accredited Program to be considered.

Due to the administrative expense associated with processing applications, we must request a $35.00 nonrefundable application fee in the form of a money order. Money orders should be made payable to: UT Houston MS-Cardiology. The application fee must be included in your application package.

After reviewing applications and letters of recommendation, we will invite a limited group for interviews. Interviews are by invitation only. Applicants selected to interview will be notified by letter or email. For this reason, it is important for you to keep us apprised of any change in your mailing or email address.

Once again, we appreciate your interest in our programs and we look forward to receiving your completed application package.

Sincerely,

Richard Smalling, MD, PhD
Professor
Program Director, Interventional Cardiology Fellowship Program

Bharat K. Kantharia, MD
Professor
Program Director, Clinical Cardiac Electrophysiology Fellowship Program

Deborah E. Meyers, MD
Associate Professor
Program Director, Heart Failure and Transplantation Fellowship Program

Application Form

Recommended Reading

1. Afterload Mismatch and Preload Reserve: A Conceptual Framework for the Analysis of Ventricular Function Progress in Cardiovascular Diseases Vol. XVIII, No. 4 January/February 1976 pp 255-263

2. The Prognostic Value of Serum Troponin T in Unstable Angina N Engl J Med, Volume 327: July 16, 1992 pp 146-150

3. Effect of Enalapril on Mortality and the Development of Heart Failure in Asymptomatic Patients with Reduced Left Ventricular Ejection Fractions Vol 327 No 10, September 3, 1992 pp 655-691

4. A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction N Engl J Med, Vol 328, No 10 * March 11, 1993 pp 674-679

5. Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia N Engl J Med, Vol 333 No 20 * November 16, 1995 pp 1301-1307

6. Extent of Early ST Segment Elevation Resolution: A Strong Predictor of Outcome in Patients with Acute Myocardial Infarction and a Sensitive Measure to Compare Thrombolytic Regimens; A Substudy of the International Joint Efficacy Comparison of Thrombolytics (INJECT) Trial JACC Vol 26, No. 7 * December 1995:1657-1664

7. The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure N Engl J Med, Vol 334, No 21 * May 23, 1996

8. Significance of initial ST segment changes for Thrombolytic treatment in first inferior myocardial infarction Heart 1997; 77:506-511

9. A Comparison of Antiarrhythmic Drug Therapy with Implantable Defibrillators in Patients Resuscitated from Near Fatal Ventricular Arrhythmias N Engl J Med, Vol 337, No 22 * November 27, 1997 pp 1576-1584

10. A Comparison of Aspirin Plus Tirofiban with Aspirin Plus Heparin for Unstable Angina N Engl J Med, Vol 338, No 21 * May 21, 1998 pp 1498-1505

11. Inhibition of the Platelet Glycoprotein IIb/IIIa Receptor with Tirofiban in unstable angina and non-Q wave Myocardial Infarction N Engl J Med, Vol 338, No 21 * May 21, 1998 pp 1488-1497

12. Complementary Clinical Benefits of Coronary Artery Stenting and Blockade of Platelet Glycoprotein IIb/IIIa Receptors N Engl J Med, Vol 341, No 5 * July 29, 1999 pp319-341

13. The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure N Engl J Med, Vol 341, No 10 * September 2, 1999 pp 709-717

14. Effects of an Angiotensin-Converting-Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients N Engl J Med, Vol 342, No 3 * January 20, 2000 pp 145-153

15. Reperfusion therapy for acute myocardial infarction with fibrinolytics therapy or combination reduced fibrinolytics therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomized trial Lancet 2001; 357:1905-1914

16. Admission Troponin T Level Predicts Clinical Outcomes, TIMI Flow, and Myocardial Tissue Perfusion After Primary Percutaneous Intervention for Acute ST-Segment Elevation Myocardial Infarction Circulation. 2001; 104:630-635

17. Comparison of Early Invasive and Conservative Strategies in Patients with unstable Coronary Syndromes Treated with the Glycoprotein IIb/IIIa Inhibitor Tirofiban N Engl J Med, Vol 344, No 25 * June 21, 2001 pp1879-1887

18. Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation N Engl J Med, Vol 345, No 7 * August 16, 2001 pp 494-502

19. Evaluation and Management of Chronic Mitral Regurgitation N Engl J Med, Vol 345, No 10 * September 6, 2001 pp740-746

20. Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction N Engl J Med, Vol 346, No 12 * March 21, 2002 pp 877-883

21. Low-Output, Low-Gradient Aortic Stenosis in Patients with Depressed Left Ventricular Systolic Function; The Clinical Utility of the Dobutamine Challenge in the Catheterization Laboratory Circulation. 2002; 106:809-813

22. Evaluation of Prolonged Antithrombotic Pretreatment (“Cooling-Off” Strategy) Before Intervention in Patients With Unstable Coronary Syndromes: A Randomized Trial JAMA, Vol. 290, No. 12 pp. 1593-1599

23. Usefulness of Dobutamine Echocardiography in Distinguishing Severe from Nonsevere Valvular Aortic Stenosis in Patients with Depressed Left Ventricular Function and Low Transvalvular Gradients Am J Cardiol 1995 Jan 15 75: 2 pp. 191-4

24. Counterintuitive Contributions to the Care of Myocardial Infarction and the Need for Randomized Trials JACC, Vol 42, No. 6, pp. 978-980

25. Patient Selection and Current Practice Strategy for Off-Pump Coronary Artery Bypass Surgery Circulation. 2003;108:II-9

26. Off Pump Coronary Artery Bypass (OPCAB) Surgery Reduces Risk-Stratified Morbidity and Mortality: A United Kingdom Multi-Center Comparative Analysis of Early Clinical Outcome Circulation. 2003;108:II-9

27. A Randomized Study of Prophylactic Catheter Ablation in Asymptomatic Patients with the Wolff-Parkinson-White Syndrome N England J Med 349:19 pp. 1803-1811

28. Alcohol Consumption and Prognosis in Patients with Left Ventricular Systolic Dysfunction After a Myocardial Infarction JACC, Vol 43, No. 11, pp 2016-2021

29. Radial Versus Femoral Approach for Percutaneous Coronary Diagnostic and Interventional Procedures JACC, Vol 44, No. 2, pp 349-356

30. ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction—Executive Summary

31. Universal Definition of Myocardial Infarction

32. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction

 

CARDIOVASCULAR FELLOWSHIP PROGRAMS

FOR PATIENTSPATIENTS.html
OUR CARDIOLOGISTSCARDIOLOGISTS.html
OUR CARDIOVASCULAR IMAGING SERVICESIMAGING.html
FOR PHYSICIANS4PHYSICIANS.html
OUR LOCATIONSLOCATIONS.html
CONTACT USCONTACTUS.html
FELLOWSHIP PROGRAM
GRAND ROUNDSGRANDROUNDS.html
CLINICAL TRIALSTRIALS.html
INTERNATIONAL PATIENTSINTERNATIONAL.html
MAKE AN APPOINTMENTAPPOINTMENTS.html
AREAS OF EXPERTISEEXPERTISE.html
Pre-Test Formsindex.html
The Patient Care Centers of
The University of Texas Medical School at Houstonhttp://med.uth.tmc.edu
En EspanolHOME_2.html